← Insider buys

Marco Londei has sold ANAB and made no open-market buys since Dec 2018

Chief Medical Officer at AnaptysBio, Inc.

SEC CIK 0001654500 · Filings on SEC.gov ↗

$0Bought
$4.1MSold
NoneLast buy

Every filing

3 filings since Dec 2018, newest first

Filings come from SEC EDGAR. Not investment advice.